Professor Kevin Pfleger

Director, Biomedical and Health Innovation

LinkedIn: https://www.linkedin.com/in/kevinpfleger/

Professor Kevin Pfleger MA(Cambridge) PhD(Edinburgh) FBPhS is Director Biomedical and Health Innovation at The University of Western Australia (UWA) and the Western Australian Life Sciences Innovation Hub. He is also Head of Molecular Endocrinology and Pharmacology at the Harry Perkins Institute of Medical Research and Chief Scientific Advisor to Dimerix Limited.

Professor Pfleger has developed globally-recognised expertise in molecular pharmacology over the last 25 years. He also has experience in research translation, being a named inventor on a number of patent families and being a spin-out company Chief Scientific Officer for more than 6 years. This company, Dimerix, of which he is now Chief Scientific Advisor, is now listed on the Australian stock exchange and is in Phase 3 clinical trials for chronic kidney disease. Professor Pfleger is also a scientific co-founder of RAGE Biotech in addition to advising and mentoring a number of other start-ups and entrepreneurs, including Perth Biodesign alumni VeinTech and Pretect Devices.

Professor Pfleger supports innovation and entrepreneurship training as Chair of both Perth Biodesign and Biodesign Australia. He was also Founding co-Director of the Australian Clinical Entrepreneur Program.